We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cayman Gs967; Purity- Greater Than Or Equal To 98%; Size- 50 Mg;
Product Description
Inhibition of cardiac late sodium current (late INa) is a strategy to suppress arrhythmias and sodium-dependent calcium overload associated with myocardial ischemia and heart failure. GS967 is a selective inhibitor of late INa that has been shown to suppress experimentally induced arrhythmias in rabbit myocytes and hearts.1 It can inhibit A. sulcata toxin II–induced late INa in ventricular myocytes and isolated hearts with IC50 values of 0.13 and 0.21 µM, respectively.1 GS967 causes minimal inhibition of the delayed-rectifier potassium current nor does it affect L- or T-type calcium channel currents, sodium-calcium exchanger currents, or a panel of 162 receptors, ion channels, transporters, and enzymes.1
WARNING This product is not for human or veterinary use.
Technical Information
- DMF: 25 mg/ml
- DMF:PBS(pH7.2) (1:2): 0.3 mg/ml
- DMSO: 20 mg/ml
- Ethanol: 12 mg/ml
Shipping & Storage Information
| SKU | CAYM-18376-50 |
|---|---|
| Featured | No |
| Supplier Part Number | 18376-50 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Cayman |
| MSDS URL | Click here |
| Temperature | -20 |
| Refrigerated-Frozen | Refrigerated |
| CountryOfOrigin | United States |
| ProductLine | CAYM |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 2 |
| Hazardous | N |
| CAS Number | 1262618-39-2 |
| Energy Star | No |
| Green | No |
| ACT Ecolabel | No |
| Controlled | N |